Related Experiment Video
Updated: Jan 7, 2026

Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
Research Trends and Insights Regarding MicroRNAs in Psoriasis: A Comprehensive Analysis
Ismail Örs1, Nur Cihan Cosansu2, Berna Solak3
1Dermatology, Meram State Hospital, Konya, TUR.
Abstract:
MicroRNAs (miRNAs) have emerged as key regulators in psoriasis, yet the global research landscape has not been systematically mapped from an informatics and translational perspective. We searched the Web of Science Core Collection on April 23, 2024, for English-language articles and reviews using "TS=(psoriasis) AND TS=(miRNA OR miR)". Records and cited references were exported as TXT/BIB. Bibliometric and network analyses were performed with VOSviewer (v1.6.18, Leiden University, Leiden, Netherlands) and the bibliometrix package in R (v4.2.1, R Foundation for Statistical Computing, Vienna, Austria). Co-authorship, co-occurrence, and citation networks were constructed with predefined thresholds; local vs. global citations were distinguished. Protein-protein/miRNA-target interactions were summarized via STRING (version/date aligned with the bibliometric window). We identified 449 publications (393 articles, 56 reviews) from 2003 to 2024, with a 13.8% annual growth and 28.5 citations per document. Thematic mapping recovered basic themes (psoriasis, keratinocytes, inflammation), motor themes (miR-146a-5p, exosomes, GAB1), and emerging terms (STAT3, adalimumab). A STRING-based summary highlighted hubs (STAT3, PTEN, TRAF6) converging on inflammatory and proliferative pathways. Translational tags co-localized "biomarker/monitoring" with core psoriasis/miRNA clusters, and drug tokens (e.g., adalimumab) appeared in emerging/motor zones, indicating a literature focus that is potentially useful for panel scoping and exploratory endpoint selection. Research on miRNAs in psoriasis shows sustained growth and a shift toward translational topics. The evidence map and prioritized miRNA hubs can inform biomarker panel selection, trial design, and clinical decision support in psoriasis.
Insights
MicroRNAs (miRNAs) are key in psoriasis research, with studies growing and shifting towards translational applications. This analysis maps the research landscape, identifying key miRNA hubs for biomarker and clinical use.
Area of Science:
- Dermatology and Bioinformatics
- Focuses on the intersection of microRNA research and psoriasis, utilizing bibliometric and network analysis for informatics and translational insights.
Background:
- MicroRNAs (miRNAs) play a crucial role in regulating biological processes relevant to psoriasis.
- The global research landscape concerning miRNAs in psoriasis lacks a systematic informatics and translational mapping.
- Understanding this landscape is vital for advancing psoriasis diagnostics and therapeutics.
Purpose of the Study:
- To systematically map the global research landscape of miRNAs in psoriasis from an informatics and translational perspective.
- To identify key themes, influential publications, and emerging trends in miRNA research for psoriasis.
- To highlight potential miRNA biomarkers and therapeutic targets for psoriasis.
Main Methods:
- Bibliometric and network analyses were conducted on publications from the Web of Science Core Collection (2003-2024).
- VOSviewer and the bibliometrix package in R were used for co-authorship, co-occurrence, and citation network construction.
- STRING database was utilized to summarize protein-protein and miRNA-target interactions.
Main Results:
- Identified 449 publications showing a 13.8% annual growth rate and high citation impact.
- Thematic mapping revealed core themes (psoriasis, inflammation), motor themes (miR-146a-5p, exosomes), and emerging terms (STAT3, adalimumab).
- Key regulatory hubs (STAT3, PTEN, TRAF6) involved in inflammatory and proliferative pathways were identified, with translational tags linking biomarkers and drug development.
Conclusions:
- Research on miRNAs in psoriasis demonstrates sustained growth and a significant shift towards translational applications.
- The identified miRNA hubs and thematic trends provide a foundation for biomarker panel selection and clinical trial design.
- This evidence map can inform clinical decision support for psoriasis management and therapeutic strategies.
Related Concept Videos
MicroRNAs
MicroRNAs
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
The JAK-STAT Signaling Pathway

